Shan Guogen, Zhang Hua, Jiang Tao
a Epidemiology and Biostatistics Program, Department of Environmental and Occupational Health, School of Community Health Sciences , University of Nevada Las Vegas , Las Vegas , NV , USA.
b School of Computer and Information Engineering , Zhejiang Gongshang University , Hangzhou , Zhejiang , China.
J Biopharm Stat. 2018;28(6):1193-1202. doi: 10.1080/10543406.2018.1452029. Epub 2018 Mar 19.
To compare a new binary diagnostic test with the gold standard, sensitivity and specificity are the two common measurements used to evaluate the new test. When not all the patients are verified by the gold standard due to time, budget, or cost considerations, several approaches have been proposed to compute sample size for such studies under the assumption of missing completely at random. However, the majority of them are based on asymptotic approaches that generally do not guarantee the type I and II error rates, and the remaining approaches use exact binomial distributions in sample size calculation but only the verified samples are used. In this article, for a study with verification bias, we propose computing exact sample sizes by using all the samples. The proposed approach is compared with the existing exact approach that compute sample size by using verified samples only, and the results show that the proposed approach requires fewer participants than the competitor.
为了将一种新的二元诊断测试与金标准进行比较,灵敏度和特异度是用于评估新测试的两个常用指标。当由于时间、预算或成本考虑,并非所有患者都通过金标准进行验证时,已经提出了几种方法来在完全随机缺失的假设下计算此类研究的样本量。然而,它们中的大多数基于渐近方法,这些方法通常不能保证I型和II型错误率,其余方法在样本量计算中使用精确二项分布,但仅使用已验证的样本。在本文中,对于存在验证偏倚的研究,我们建议使用所有样本计算精确样本量。将所提出的方法与仅使用已验证样本计算样本量的现有精确方法进行比较,结果表明所提出的方法比竞争对手需要的参与者更少。